Eye Research Australia Foundation
Charity in Melbourne

The center for Eye Research Australia (ERA) was established in 1996 and has grown into Australia’s leading eye research institute. Michael has been researching surgical solutions for Glaucoma for over 20 years and is a consultant to the Glaucoma Clinic at Hospital. His main research interests are in cornea and external disease and stem cell surgery, as healthy as surgery of the cornea and lens. Mark’s research at ERA is into corneal stem cell transplantation. After a two year self funded fracture from research, he returned in July 2013 to pursue his Health Services research in diabetes and diabetic eye disease, with a focus on eye service delivery and evaluative research. He returned to Melbourne in 2013 to receive up the position with ERA’s Clinical Genetics. In 2014, Dr Reed was awarded a NHMRC Career Development Fellowship to thrive her research program focused on four themes: investigating behavioral and psychological factors that contribute to the prevention and management of eye disease developing and validating patientcentred outcome measures developing and evaluating novel interventions to improve patient centredoutcomes implementation research to translate evidence based interventions into eye care services. He has been a non executive director of abundant private tall growth companies and has worked extensively with management teams and boards in setting strategies and driving operational improvements. The Finance and Risk Committee, which reports to the Board, reviews the financial planning and management of the company, financial reporting and statutory compliance obligations, and oversees risk management, investments and commercialization activities. ERA has grown out of the University of Melbourne Department of Ophthalmology, which was established in 1963. The center for Eye Research Australia is an active member and project partner in a number of eye health collaborations and networks. ERA is an active member of Vision 2020 Australia, a national membership body of some 50 eye health and vision impairment encourage organizations busy in partnership to prohibit avoidable blindness and improve vision care. What is involved in clinical trials for eye conditions? There are generally more assessments needed for a clinical trial than for a standard clinic appointment, however the waiting time between assessments is usually less. Many studies involve injections into the eye. Injections into the eye are a regular procedure for the treatment of many eye conditions. Our trials team of over 40 trial ophthalmologists, orthoptists and scientists have expertise in diseases including: age related macular degeneration, glaucoma, uveitis, diabetic eye disease, corneal eye disease, retinal disease (retinal vein occlusion), and bionic vision research. Is based at two main sites in East Melbourne. Management of an eye trials research network. Our observe coordinators are experienced clinical orthoptists and clinical observe managers. To apply evidence through research to improve the effectiveness and the quality of eye concern services which are close to all. Professor He has led a series of studies to assist grasp the prevalence, clinical characteristics, instinctive history and risk factors for imperative eye diseases such as glaucoma, myopia and retinal diseases.His research interests include: clinical and epidemiological research, randomized clinical trials, twin studies and imaging technology. He has a exceptional interest in public health, transnational research and innovative solutions to improve health protection access and efficiency. The doctor certifying a patient’s death is not involved with the eye donation or with the transplant.